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Kawasaki disease (KD) is a systemic vasculitis characterized by fever, cervical
lymphadenopathy, conjunctival injection, oral lesions, indurative edema, late
desquamation of extremities, and polymorphous skin rashes. Complications of
KD include coronary artery aneurysms and thrombosis, making it an important
cause of acquired heart disease in children.1 Clinical and epidemiological features
strongly suggest that the etiology of KD is an infection.2 These include young age
of affected individuals range, (6 months to 5 years old), clinical features of the
illness such as fever and self-limited course, the occurrence of epidemics with
periodicity, and the geographic wave-like spread of illness during epidemics.2
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Purpose: Kawasaki disease is a systemic vasculitis, and its etiology and pathogenesis are still not clear. Our study
was undertaken to investigate the characteristics of the activation of B cells in the peripheral blood of Kawasaki
disease (KD) patients and evidence of stimulation by superantigens. Materials and Methods: Blood samples were
obtained from three patients (2 males, 1 female) with KD, who were admitted to our Hospital, Seoul, Korea. The
mean age was 1.2 years. Distribution of B cells was studied in the acute and subacute phases of KD patients. From
the RNA of B cells, we obtained complementary DNA (cDNA) and performed polymerase chain reaction (PCR).
To determine the oligoclonal expansion of immunoglobulin M (IgM) VH family, we cloned and sequenced the PCR
products from each group and analyzed DNA. Results: In the peripheral blood of acute phase patients, T cells were
significantly decreased (p < 0.05), whereas B cells were significantly increased (p < 0.05). When the first PCR was
done on the B cell chains, VH1 to VH6 were all found to be expressed. The number of µ gene clones obtained from 3
patients was 312, and they belonged to VH3, VH4 and VH5 family. M99686 germ line was most frequently used and
the next most frequently used, were X92224/J, L21967 and L21964. A similar order was seen in patients. Among
the clones, 20 sets of clones showed the same base sequence and this was frequent between VH2 and VH5. There
was one set, which showed almost the same base sequence between different patients, and the homology was
99.5%. Twenty sets of clones that had the same base sequence showed high similarity to the germ line (94 - 100%).
Among these, the clones that utilized the M99686 germ line were 4 sets which were most frequent. The 3-
dimensional structure of one of these clones showed typical β‚ sheet structure of immunoglobulin chains.
Conclusion: The IgM transcripts expressed by the B cells in the peripheral blood of KD patients in the acute phase
of the disease clearly showed an oligoclonal expansion, suggesting that KD is caused not by stimulation of a
superantigen, but rather by a conventional antigen.
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Immunologic mechanisms are thought to be important
in disease activation, progression, and complications. The
selective expansion of T cells expressing Vβ2 and Vβ8
families in the peripheral blood of acute KD patients has
been observed, suggesting the involvement of superan-
tigens.3 Based upon a single study,4 toxic shock syndrome
toxin-1 or streptococcal superantigens were proposed to be
related etiologically to KD, however, other investigators
have not been able to confirm these findings. Over the past
few years, it has been debated whether KD is developed as
a response to a superantigen or to a conventional antigen.
Rowley et al.5 reported that immunoglobulin (Ig) A
produced in acute KD vascular tissue is oligoclonal, con-
sistent with an antigen-driven immune response. In young
infants, primary antigenic stimulation of peripheral blood
induces B cells to predominantly secrete IgM.6,7 In this
study, we examined the clonality of the IgM response in
peripheral blood during acute phase of the disease to
determine actual immunologic response. 
Patients
Blood samples were obtained from 3 patients (2 males, 1
female) with KD, who were admitted to our Hospital, Seoul,
Korea. All patients satisfied at least 5 of the 6 diagnostic
criteria for KD.8 They exhibited typical clinical symptoms
and signs of KD, and did not have any complications of
coronary artery aneurysm during 6 months after diagnosis.
The mean age was 1.2 years (11, 15, and 18 months). All
patients were treated with intravenous gammaglobulin in
addition to high-dose aspirin. Whole blood was collected
during the acute diagnostic phase before the initiation of
any therapy and convalescent phase after therapy. Blood
samples from the patients were obtained on the first day of
diagnosis for each child and again on the 7th day of diag-
nosis during the convalescent phase. Informed consent was
obtained from the parents of the patients included in the
study.
Cell preparation, RNA isolation and cDNA synthesis
Mononuclear cells were isolated by Ficoll-Hypaque density
gradient centrifugation, followed by B cell separation using
anti-CD19-coated magnetic beads (Dynabeads M450 Pan
B; Dynal, Oslo, Norway). Messenger RNA (mRNA) was
isolated from 1× 106 B cells by using the Oligotex Direct
mRNA-Kit (Quiagen Inc., Chatsworth, CA, USA), and com-
plementary DNA (cDNA) was prepared with the Supers-
cript Preamplification System (GIBCO BRL, Gaithers-
burg, MD, USA) and a random hexamer nucleotide mix. 
Amplification of VH genes
For analysis of VH genes, a set of 5’ primers specific for
human VH1, VH2, VH3, VH4, VH5, and VH6 gene families in
combination with a 3’ primer specific for the first exon of
the µ constant region were employed (Table 1).9
All polymerase chain reaction (PCR) reactions were
performed in a final volume of 100 µL with 20 pmol each
of primer, 200 µM dNTP, 2.5 U of Taq DNA Polymerase
(Promega, Madison, WI, USA) and 10 µL of 10 × reaction
buffer. Amplification was performed in a thermal cycler
and consisted of 35 cycles of 1 min denaturation at 95˚C, 1
min primer annealing at 58˚C, and 1.5 min extension at
72˚C, with a final extension of 5 min at 72˚C PCR pro-
ducts were analyzed in a 2% agarose gel, slices containing
the specific band of 500 bp were excised, and DNA was
purified using QIAquick Gel Extraction Kit (Quiagen).
Cloning of PCR products 
Cloning of the PCR product was performed using pCR®
2.1-TOPO® kit and One Shot® competent E. coli (Invitro-
gen, Carlsbad, CA, USA) according to the manufacturer’s
protocol. After mixing PCR products and using pCR® 2.1-
TOPO® vector, ligation was performed for 5 min at room
temperature. One Shot® competent E. coli was mixed and
incubated for 5 min on ice. Then, SOC culture media were
added after heating for 30 sec in a 42˚C water bath. After
incubation in selective media containing X-gal (Sigma Co.,
St. Louis, MO, USA) and ampicillin (100 µg/mL), trans-
formed positive clones were selected. After these clones
MATERIALS AND METHODS
Table 1. Sequences of Primers Used for Specific Amplification of IgM VH Transcripts
Sense
VH 1 5’-CCATCGACTGGACCTGG-3’
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were cultured in Luria-Bertani media containing ampicillin
(100 µg/mL), plasmids were obtained and DNA was
quantified using QIAprep® Miniprep kit (Qiagen, Valencia,
CA, USA). 
Sequencing of DNA
After plasmid DNA was mixed with BigDye® terminator
mix (PE Applied Biosystems, Foster City, CA, USA) and
sequencing primer, DNA was amplified for 10 sec at 96˚C,
5 sec at 50˚C, and 4 min at 60˚C for 25 cycles. Amplified
DNA was washed with ethanol, and sequences were deter-
mined with an ABI PRISM® 310. Each sequence was
analyzed directionally using M13 forward primer (5’-
GTAAAACGAGGCCAG-3’) and M13 reverse primer
(5’-CAGGAAACAGCTATGAC-3’) by Macrogen Co.
Ltd (Seoul, Korea). Sequences were compared using DNA
sequencing analysis software (PE Applied Biosystems,
Wellesley, MA, USA) and DNAssist v 2.0 (Bellville,
South Africa). These sequences were also compared with
VH complementarity determining regions (CDRs) and
human immunoglobulin germ line genes using http://imgt.
cines.fr and advanced Blast search program from the
Genbank data base (National Center for Biotechnology
Information, NIH, Bethesda, MD, USA).
Distribution of T and B cells in Kawasaki disease
We observed significantly decreased T cells (p < 0.05) and
increased B cells (p < 0.05) during the acute phase, when
blood samples during the acute and convalescent phase
were separately analyzed (Table 2). Serum IgM showed no
significant difference during the acute phase (988 ± 218
mg/dL) compared to control group (1046 ± 264 mg/dL).
Serum IgM level was increased to 2723 ± 259 mg/dL 24
hours after administration of intravenous gammaglobulin,
and the increased level was maintained at 2470 ± 311
mg/dL 7 days thereafter.
Identification of immunoglobulin V chain gene by RT-
PCR 
Reverse transcription polymerase chain reaction (RT-PCR)
was performed to identify oligoclonal expansion of heavy
chains in B-cells of peripheral blood during acute phase.
As shown in Fig. 1, all heavy chains from VH1 to VH6 were
evenly distributed.





T cell 62.5 ± 9.5* 69.2 ± 7.9 70.0 ± 7.2
B cell 14.8 ± 6.5* 13.1 ± 6.0 8.4 ± 3.5
Peripheral blood mononuclear cells were stained with anti-CD19 or anti-CD3 monoclonal antobodies and total 5,000 to 20,000 cells were 
analyzed.
*p < 0.05 compared with normal controls. 
RESULTS
Table 3. Distribution of µ Gene Clones from cDNA of 3 Korean Patients with Kawasaki Disease
Patient VH1 VH2 VH3 VH4 VH5 VH6 Total
1 10 15 17 24 17 18 101
2 13 15 17 20 20 14 99
3 12 18 23 21 20 18 112
Total 35 48 57 65 57 50 312
cDNA, complementary DNA.
Fig. 1. Amplification of V regions of Ig µ heavy chain genes (VH1 - VH6) by RT-PCR.
M, marker; RT-PCR, reverse transcription polymerase chain reaction.
M VH1 VH2 VH3 VH4 VH5 VH6 
IgM
VH family utilization in µ transcripts
The nucleotide and amino acid sequences of a total of 312
clones were analyzed (Table 3). A total of 101 clones from
patient #1, 99 clones from patient #2 and 112 clones from
patient #3 were analyzed. In all three patients, a preferential
usage or deletion of a certain VH family seemed to be unlikely.
VH gene utilization 
Fifty-four out of 312 clones (17.3%) used M99686 germ
line gene of the VH5 family which was the most frequently
used clone for the 3 patients. The X92224/J of the VH6
family was the second most frequently used (48 out of 312
clones: 15.4%) (Table 4). These findings suggest that there
is a clonal relation among the respective B cells.
Somatic mutations in the µVH segments
The VH gene segments were aligned to the germ-line
sequence sharing the highest nucleotide identity. In general,
both mutated and unmutated VH genes were found to be
expressed in IgM-producing B cells of patients with KD.
Eighty seven percent (47/54) of M99686 derived clones
were more than 98% identical to the germ-line gene at the
nucleotide level, and 70.8% (34/48) of X92224/J derived
clones displayed greater than 98% homology. Two M99686
derived clones (clone #5-1-6 and clone #5-3-10) and 3
X92224/J derived clones (clone #6-1-20, clone #6-2-14 and
clone #6-3-5) displayed extensive somatic mutations,
especially in the FR3 region, whereas others showed only
a few somatic mutations and some showed nearly identical
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Yonsei Med J   http://www.eymj.org    Volume 50   Number 4   August 2009496
Table 4. Frequently Used Germ Lines in Each Patient







family clones family clones family clones
L06612 V1 5 X62110 V1 4 M99641 V1 7
M99641 V1 2 X62106 V1 3 M83132 V1 3
M99637 V1 2 L06612 V1 2 L06612 V1 2
X62110 V1 1 M99641 V1 2 L21967 V2 6
L21967 V2 8 L22582 V1 1 L21969 V2 7
L21964 V2 6 X62109 V1 1 L21964 V2 5
L21972 V2 1 L21967 V2 7 M99660 V3 5
Z12353 V3 2 L21964 V2 6 M99672 V3 3
X92206 V3 2 L21969 V2 2 X92287 V3 3
M99652 V3 4 M99660 V3 8 L06618 V3 2
M99660 V3 2 M99649 V3 3 L33851 V3 2
M99649 V3 2 L06618 V3 1 M99679 V3 2
M99679 V3 1 M99406 V3 1 X92214 V3 2
L33851 V3 1 X92206 V3 1 M99676 V3 1
L06618 V3 1 X92216 V3 1 X92216 V3 1
J00239 V3 1 Z12351 V3 1 X92287 V3 1
L10089 V4 11 X92278 V4 5 Z12351 V3 1
L10088 V4 2 L10088 V4 4 Z12353 V3 5
L10094 V4 2 L10094 V4 1 L10088 V4 5
M99684 V4 1 L10097 V4 2 L10094 V4 3
X62112 V4 2 M99684 V4 2 X92278 V4 5
X92278 V4 5 X62112 V4 2 M29811 V4 1
M99686 V5 17 X92259 V4 2 X05715 V4 1
X56358 V5 1 M95113 V4 1 X62112 V4 1
X92224/J V6 16 Z14237 V4 2 X92232 V4 1
Z14223 V6 2 M99686 V5 17 M99686 V5 20
M18860 V5 2 X92224/J V6 18
X92227 V5 1
X92224/J V6 14
Total 101 99 112
germ-line. The M99686 derived clones differed in a number
of replacement mutations, mainly in CDR2, however,
mutations in X92224/J derived clones were distributed
more or less randomly over both CDR and FR segments
(Figs. 2-7). Interestingly, two clones (clone #5-1-8 and
clone #5-3-4) from 2 different patients were almost identical
(Fig. 8). These were M99686 derived clones.
D and JH gene usage in µ transcripts
The analyzed CDR3 gene segments of M99686 derived
clones appeared to differ markedly in length, ranging from
20 to 29 amino acids of 60 - 87 nucleotides (Fig. 3), while
the analyzed CDR3 gene segments of X92224/J derived
clones appeared to differ markedly in length, ranging from
15 to 34 amino acids of 45 - 102 nucleotides (Fig. 5).
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FR1 CDR1 FR2 CDR2 FR3
5-1-1 ......................... ........ ................. ........ ......................................
5-1-2 ......................... ......H. ................. ........ ......................................
5-1-3 ......................... ......H. ................. ........ ......................................
5-1-4 ..R.........E.....Q...... ..R.SD.. .A.......E....... .F....Q. .F.........M......N.V...........S..FF.
5-1-5 .A....................... ......H. ................. ........ ........R.............................
5-1-6 ......................... ......H. ......T.......... ........ ......................................
5-1-7 ......................... ........ ................. ........ ...........................PEGLGHRHVLLCETLDEW
5-1-8 ......................... ........ ................. ........ ......................................
5-1-10 ......................... ....ST.. .......S......... ........ ......E.L........T..........R.........
5-1-11 ......................... ........ ................. ........ ......................................
5-1-12 ......................... ......H. ................. ........ ......................................
5-1-13 ......................... ......H. ................. ........ ......................................
5-1-14 ......................... ........ ................. ........ ......................................
5-1-15 ......................... ......HR ................. ........ ......................................
5-1-16 ........S................ ........ .A............... ........ ........H............H................
5-1-17 ......................... ......H. ................. ........ .......S..............................
5-1-18 ........S................ ........ .A............... ........ ........H............H...............
5-2-1 ......................... ......H. ................. ........ ......................................
5-2-2 ......................... ......H. ................. ........ ......................................
5-2-3 ......................... ........ ................. ........ ......................................
5-2-4 ......................... .....N.. ....H............ ......E. ..........................G...........
5-2-5 ......................... ........ ................. ........ ......................................
5-2-6 ......................... ......H. ................. ........ ......................................
5-2-7 ......................... ......H. ................. ........ ..........A...........................
5-2-8 ......................... ........ ................. ........ ......................................
5-2-9 ......................... ......H. ................. ........ ......................................
5-2-10 ......................Q.. ..N.ATH. ................. ........ ...............T...II.................
5-2-11 ......................... ..R..T.. ................. ........ .........L..L..V...V..........E.....V...
5-2-12 ......................... ......H. ................. ........ ......................................
5-2-14 ......................... ........ ................. ........ ..................N...................
5-2-16 ......................... ........ ................. ........ ......................................
5-2-18 ......................... ........ ................. ........ ......................................
5-2-19 ......................... ......H. ................. ........ ......................................
5-2-20 ......................... ......H. ............G.... ........ ...........M..........................
5-3-1 ......................... ......H. ................. ........ ............................E.........
5-3-2 ......................... ........ ................. ........ ......................................
5-3-3 ......................... ........ ................. ........ ......................................
5-3-4 ............R............ ........ ................. ........ ......................................
5-3-5 ....A.................... ......H. ................. ........ ......................................
5-3-6 ......................... ......H. ................. ........ ......................................
5-3-7 ......................... ......H. ................. ........ ......................................
5-3-8 ......................... ......H. ................. ........ ......................................
5-3-9 ......................... ......H. ................. ........ ......................................
5-3-10 ......................... ......H. ..............V.. ........ ...........................PEGLGHRHVLLCEEYNIQLVRPL
5-3-11 ......................... ........ ................. ........ ......................................
5-3-12 ......................... ........ ................. ........ ......................................
5-3-13 ......................... ........ ................. ........ ......................................
5-3-14 ......................... ......H. ................. ........ ......................................
5-3-15 ......................... ......H. ................. ........ ......................................
5-3-16 ...P..................... ......H. ....C............ ........ ..........A...........................
5-3-17 ......................... ........ ................. ........ ......................................
5-3-18 ......................... ......H. ................. ........ ......................................
5-3-19 ......................... ......H. ................. ........ ......................................
5-3-20 ................A........ ......H. ................. ........ ......................................
Fig. 2. The deduced amino acid sequences of VH germ line gene segments of 54 clones isolated from three different patients are shown in
comparison with germ line M99686. 
There has been much controversy as to whether a superan-
tigen or conventional antigen plays a role in KD.10,11 Evi-
dence in support of the superantigen theory is that KD is
clinically similar to toxin-mediated diseases such as toxic
shock syndrome, supported by an increase in peripheral T
cells with Vβ2 family T cell receptors (TCR). Furthermore,
the isolation of toxin-producing staphylococcus from KD
patients gives credence to this theory.4 However, others
failed to isolate staphylococcus from KD patients. 
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VH D/J CµM
5-1-1 TGTGCGAGG AGTACAACACACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-1-2 TGTGCGAGA CGCACTTTTACTATGATAGTCGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-1-3 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-1-4 TGTGCGAGA TTTGGGGCTCCGACCTTCTCGGGAAATTATTATGACTTTTGGGGCCAGGGAACCCAGGTTACCGTCTCCTCG GGGAGTGCACCC
5-1-5 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-1-6 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-1-7 TGTGCGAGA CATTGGATGAGTGGTAGCTGCTACCCCGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-1-8 TGTGCGAGA CGGCCTTATTACGATATCTTGACTGGCTCTGATGCTTTTGACATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA GGGAGTGCATCC
5-1-10 TGTGCGAGG GCCCAGTATAACTGGGTAACAAACGCACACCGCTACTTTGACTACTGGGGCCAGGGAAGCCGGGTCACCGTCTCCTCA GGGAGTGCATCC
5-1-11 TGTGCGAGA CTAGGCGTAGAGATGGCTACAACGCCGGGCTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-1-12 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-1-13 TGTGCGAGG AGTACAACATACAACTGGTTTGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-1-14 TGTGCGAGA CTAGGCGTAGAGATGGCTACAACGCCGGGCTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-1-15 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-1-16 TGTGCGAGA CATCCGGGGCAGCAGTGGCCGTCTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-1-17 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-1-18 TGTGCGAGA CATCCGGGGCAGCAGTGGCCGTCTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-2-1 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-2-2 TGTGCGAGA CAGGGGTACCAGCTGCTCACCGCGAATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA GGGAGTGCATCC
5-2-3 TGTGCGAGA CAATCGGTCGGATATTGTAGTAGTACCAGCTGCATAGGGCATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACC GGGAGTGCATCC
GTCTCTTCA
5-2-4 TGTGCGAGA CTGGGGCCAGGGGGGTATAGCAGTGGCATTGACTCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-2-5 TGTGCGAGA CTGGATTACTATGGTTCGGGGTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-2-6 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-2-7 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-2-8 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-2-9 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-2-10 TGTGCGAGG ATGGACTACGGTGGTAGTGAATTGGTTGACTCCTGGGGCCAGGGAACCCTGGTCAGCGTCTCCTCA GGGAGTGCATCC
5-2-11 TGTGCGAGA CAGGGTGGTAACTCCGTCTCGATTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCC GGGAGTGCATCC
5-2-12 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-2-14 TGTGCGAGA TGGGGCTCGCCTAGTTTGACGGTGGTGACCTTTGACTTCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-2-16 TGTGCGAGA ACGGGGGCGAATAGTGGGAGCCGCCCCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA GGGAGTGCATCC
5-2-18 TGTGCGAGA CTGTTATGGCCGAACTATTGGAGCAGCTGGTTCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-2-19 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-2-20 TGTGTGAGA CGGGCGGGTTACTATGGTTCGTCACAAAACTACGGTATGGACGTCTGGGGCCAAGGGACCGCGGTCACCGTTTCCTCA GGGAGTGCATCC
5-3-1 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-3-2 TGTGCGAGA CTAAGGAGTCATTACTATGGTTCGGGGAGTTATCAGAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTC GGGAGTGCATCC
TCCTCA
5-3-3 TGTGCGAGA CGGCCTTATTATGATATCTTGACTGGCTCTGATGCTTTTGACATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA GGGAGTGCATCC
5-3-4 TGTGCGAGA CGGCCTTATTACGATATCTTGACTGGCTCTGATGCTTTTGACATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA GGGAGTGCATCC
5-3-5 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-3-6 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-3-7 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-3-8 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-3-9 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-3-10 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-3-11 TGTGCGAGG GGCTACTATGATAGTAGTGGTTATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-3-12 TGTGCGAGA CGGCCTTATTACGATATCTTGACTGGCTCTGATGCTTTTGACATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA GGGAGTGCATCC
5-3-13 TGTGCGAGA CATTCCTCGGGTATAGCAGCAGCTGGTACTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-3-14 TGTGCGAGG AGTACAACGTACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-3-15 TGTGCGAGA CGGCCTTATTACGATATCTTGACTGGCTCTGATGCTTTTGACATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA GGGAGTGCATCC
5-3-16 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-3-17 TGTGCGAGA CGGCCTTATTGCGATATCTTGACTGGCTCTGATGCTTTTGACATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA GGGAGTGCATCC
5-3-18 TGTGCGAGG AGTACAACATACAACTGGCTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-3-19 TGAGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
5-3-20 TGTGCGAGG AGTACAACATACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCGCCGTCTCCTCA GGGAGTGCATCC
Fig. 3. The nucleotide sequences of CDR3 / FR4 and adjacent regions of VH germ line gene segments of 54 clones homologous to M99686 isolated from 3 different
patients are shown in comparison with germ line M99686. 
DISCUSSION
In the study on the mechanism of immunoglobulin in the
treatment of KD patients, Leucht et al.12 found that B-cells
were produced as a response to superantigens, and Duong
et al.13 reported that superantigens were the cause of the
damage to coronary arteries in mice model of KD. On the
other hand, however, many other studies have shown that
KD arises from a conventional antigen stimulus rather than
a superantigen stimulus. Choi et al.14 studied T cell response
to superantigens, and reported clonal expansion of CD8+ T
cells to a conventional antigen, however, they could not
demonstrate an increase of  T cells with Vβ family TCR to
a superantigen stimulus in peripheral blood of KD patients. 
Post-mortem examination of patients who died of com-
plications from Kawasaki disease showed infiltration of
coronary arteries by IgA-producing plasma cells, providing
further evidence that KD is due to a conventional antigen
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Clone No FR1 CDR1 FR2 CDR2 FR3 FR CDR HomologyS R S R S R S R S R S R S R (%)
5-1-1 0 0 1    0 0 0 1    0 0    0 0   0 2 0 99.4
5-1-2 1 0 0 1 0 0 0 0 0 0 1 0 0 1 99.4 
5-1-3 1 0 0 1 0 0 0 0 0 0 1 0 0 1 99.4
5-1-4 3   3 2 3 2 2 2 2 5 7 10 12 4 5 90.1
5-1-5 1 1 0 1 0 0 0 0 0 1 1 2 0 1 98.7
5-1-6 1 0 1 0 0 0 1 0 0 18 1 18 2 0 82.0
5-1-7 0 0 0 0 0 0 0 0 1 0 1 0 0 0 99.7
5-1-8 1 0 1 0 0 0 1 0 0 0 1 0 2 0 99.0
5-1-10 1 0 2 1 1 0 0 0 6 0 8 0 2 1 96.5
5-1-11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100.0 
5-1-12 1 0 0 1 0 0 0 0 0 0 1 0 0 1 99.4
5-1-13 1 0 0 1 0 0 0 0 0 0 1 0 0 1 99.4
5-1-14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100.0 
5-1-15 1 0 0 2 0 0 0 0 0 0 1 0 0 2 99.0
5-1-16 0 1 0 0 0 1 0 0 0 2 0 4 0 0 98.7
5-1-17 1 0 0 1 0 0 0 0 0 2 1 2 0 1 98.7
5-1-18 0 1 0 0 0 1 0 0 0 2 0 4 0 0 98.7
5-2-1 1 0 0 1 0 0 0 0 0 0 1 0 0 1 99.4
5-2-2 1 0 0 1 0 0 0 0 0 0 1 0 0 1 99.4
5-2-3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100.0
5-2-4 1 0 0 1 0 1 0 1 1 1 2 2 0 2 98.1
5-2-5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100.0
5-2-6 1 0 0 1 0 0 0 0 0 0 1 0 0 1 99.4
5-2-7 1 0 0 1 1 0 0 0 0 1 2 1 0 1 98.7
5-2-8 1 0 1 0 1 0 1 0 0 0 2 0 2 0 98.7
5-2-9 1 0 0 1 0 0 0 0 1 0 2 0 0 1 99.0
5-2-10 1 1 1 4 0 0 2 0 4 3 5 4 3 4 94.9
5-2-11 0 0 0 2 0 0 2 0 1 6 1 6 2 2 96.5
5-2-12 1 0 0 1 0 0 0 0 0 0 1 0 0 1 99.4
5-2-14 1 0 2 0 1 0 2 0 0 1 2 1 4 0 97.8 
5-2-16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100.0
5-2-18 0 0 0 0 0 0 0 0 1 0 1 0 0 0 99.7
5-2-19 0 0 0 1 0 0 1 0 0 0 1 0 0 1 99.4
5-2-20 1 0 1 1 1 1 0 0 2 0 4 1 1 1 98.4
5-3-1 1 0 0 1 0 0 1 0 0 1 1 1 1 1 98.7
5-3-2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100.0 
5-3-3 1 0 0 0 0 0 0 0 3 0 4 0 0 0 98.7
5-3-4 0 1 0 0 0 0 0 0 3 0 3 1 0 0 98.7
5-3-5 1 1 0 1 0 0 1 0 1 0 2 1 1 1 98.4
5-3-6 1 0 0 1 0 0 0 0 0 0 1 0 0 1 99.4
5-3-7 1 0 0 1 0 0 0 0 0 0 1 0 0 1   99.4
5-3-8 1 0 0 1 1 0  0 0 0 0 2 0 0 1   99.0
5-3-9 1 0  0 1 1 0  1 0 1 0 3 0 0 1  98.7
5-3-10 1 0  0 1 0 1  0 0 0 23 1 24 0 1 77.7
5-3-11 3 0  1 0 0 0  0 0 0 0 3 0 1 0   98.7
5-3-12 0 0  0 0 0 0  0 0 3 0 3 0 0 0 99.0
5-3-13 1 0  0 0 0 0  0 0 0 0 1 0 0 0 99.7
5-3-14 1 0  0 1 1 0  0 0 1 0 3 0 0 1 98.7
5-3-15 1 0  0 1 0 0 0 0 1 0 2 0 0 1 99.0
5-3-16 1 1 0 1 0 1 0 0 0 1 1 3 0 1 98.4
5-3-17 1 0  1 0 1 0  0 0 0 0 2 0 1 0 99.0
5-3-18 1 0  0 1 0 0  0 0 0 0 1 0 0 1 99.4
5-3-19 1 0  0 1 0 0  0 0 1 0 2 0 0 1 99.0
5-3-20 1 1  0 1 0 0  0 0 0 0 1 1 0 1   99.0
Fig. 4. Mutation analysis of 54 M99686 derived clones from the peripheral B cells of 3 different patients.
stimulus.15 IgA-mediated immune mechanism is thought to
be due to an antigen stimulus in which the antigen invades
the mucosal barrier of the host. Recently, Rowley et al.16
reported that KD-associated antigen may be present in
cytoplasmic inclusion bodies of ciliated bronchial epithelial
cells in acute fatal cases. These inclusions would be aggre-
gates of viral proteins and nucleic acids. These findings
suggest a common, persistent RNA virus of conventional
antigen as the etiological agent of KD. 
Though there has been active research going on whether
KD is due to a conventional antigen or superantigen through
T-cell activation, there are only a few reports on B-cell
activation. Barron et al.17 were the first to study the B-cell
activation and reported that polyclonal IgM and IgG
antibodies were increased. The presence of cytotoxic anti-
bodies against endothelial cells in the sera of KD patients
was reported, and these antibodies which react against
endothelial antigens are thought to be activated by cyto-
kines.18,19 Kim et al.20 reported that the B-cell clones which
contained unusually long (11 amino acid codons) VkIII
derived light chain CDR3 regions proliferated significantly
in the acute phase of KD and decreased in the convalescent
phase. Although they reported the expansion of immuno-
globulin light chain clones, however, the study did not
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FR1 CDR1 FR2 CDR2 FR3
6-1-1 ...........ME............ ......TG.. ................. .F....... ...A...G....D.......L.............I...
6-1-2 ......................... .......... ................. ...G..... ..........N..A.........H..............
6-1-3 ......................... .......... ................. ......... ..........S........................F..
6-1-5 ......................... .......... .I............... ........Y ..........I........*..................
6-1-6 ......................... .......... ................. ......... ......................................
6-1-7 ......................... .......... ................. ......... ......................................
6-1-8 ......................... .......... ................. ......... ......................................
6-1-9 ......................... .......... ................. ......... .....E................................
6-1-10 ......................... .......... ................. ......... N.........S........................F..
6-1-11 ......................... .......... ................. ......... ......................................
6-1-12 ......................... .......... ................. ....P.... ...A..............S...................
6-1-13 ......................V.. ..G....... ................. ......... ...P......N.........V.................
6-1-15 ................A........ .......... ................. ......... ......................................
6-1-16 H........................ .......... .T............... ..F...... G..A...G.................S............
6-1-18 ......................... .......... ................. ......... ......................................
6-1-20 ......................... .......... ................. ....... **LCSICEKSNNHQPRHIQEPVLPAAELCDSRGHGCVL
6-2-1 ................A.....G.. .....NSG.. .....L........... .F.M.R.ST E.S....N....S....R.....E..............
6-2-3 ......................... .......T.. ................. .F.....K. ......Q....V...A....................F.
6-2-4 ......................... .......NV. .H............... ........T ....P.....S...........................
6-2-5 ......................... ......... ................. ......... ......................................
6-2-6 ........S................ .G...D.... ................. ......... ...E...................L..............
6-2-8 ......................... .........V ................. ..F..Q... ...E......I......R..................F.
6-2-12 ......................... .....N.G.T ................. ........Y .....................Y.....LA.....M...
6-2-13 ......................... .......... ................. ......... ......................................
6-2-14 ......................... .......... ................. ......... ........................PELCDSRGHGCVLL
6-2-15 ......................... .......... ................. ......... ......R..M...............K............
6-2-16 ......................... .......... ................. ......... ......................................
6-2-18 ...........L............. .......VS. ................. ........Y .........V.......Q....................
6-2-19 ......................... .......... .H............... .F....... ......................................
6-2-20 ......................... .......... ................. .......F. .......G..............................
6-3-1 ......................... .......... ................. ......... ..................................G...
6-3-2 ......................... .......... ................. ......... ......................................
6-3-3 ......................... .......... ................. ......... ......................................
6-3-4 ......................... .......... ................. ......... ......................................
6-3-5 ......................... .......... ................. ......C*. L*LPRTRLC..VQERV.EQ.LVNPHLTTGAREPWSPSP
6-3-6 ........................ .......... ................. ......... ......................................
6-3-7 ......................... .......... .............*... ......... ......................................
6-3-8 ......................... .......... ................. ......... ..T...................................
6-3-9 ......................... .......... ................. ......... ......................................
6-3-10 ......................... .......... *................ ......... ......................................
6-3-11 ......................... .......... ................. ......... .....................................
6-3-12 ......................... .......... ................. ......... ......................................
6-3-14 ......................... .......... ................. ......... ......................................
6-3-15 ..H...................... .......... .S............... .N....... ......................................
6-3-16 ......................... .......... .............R... ......... ......................................
6-3-17 ......................... .......... ................. ......... ......................................
6-3-19 ......................... .......... ................. ......... ......................................
6-3-20 ...................P..... .......... ................. ......... .............................S........
Fig. 5. The deduced amino acid sequences of VH germ line gene segments of 54 clones isolated from 3 different patients are shown in comparison
with germ line X92224/J. 
demonstrate oligoclonality through sequencing. Interes-
tingly, in a post-mortem study of KD patients, Rowley et
al.5 reported that the plasma cells infiltrating the coronary
arteries were mostly IgA and IgM-secreting cells, and that
oligoclonal IgA reactivity could be observed, suggesting
that KD is caused by conventional antigens rather than
superantigens.15
However, when the peripheral blood of infants is stimul-
ated with a polyclonal stimulus, IgM is secreted mostly by
B-cells, while there are few IgG and IgA-secreting B-
cells.6,7 The increase in IgG and IgA-secreting B-cells is
observed at 1-2 years of age. Moreover, the primary immune
reaction takes place first when the antigen is introduced
into the host, and it is well known that the characteristics of
this reaction is that IgM is mostly produced. The affinity
and specificity of the antibodies for this antigen is low, and
IgM VH Chain Gene Analysis in Kawasaki Disease
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VH D/J CµM
6-1-1 TGTGCAAGA GAGGGCGGTGGGAACTACTTGTACTACTTTGACTACTGGGGCCAGGGAGCCCAGGTCACCGTCTCCTCA GGGAGTGCATCC
6-1-2 TGTGCAAGG TCGCATACCAACAACTTGGGCTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-1-3 TGTGCAAGA GGTCATAGCAGTGACTTGTCCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA GGGAGTGCATCC
6-1-5 TGTGCAAGA GGGCCCCACGCTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCGCA GGGAGTGCATCC
6-1-6 TGTGCAAGA GCTAGGGACCCGTGGACAAATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA GGGAGTGCATCC
6-1-7 TGTGCAAGA GAGGGCCCCCTAAGGAACGGCTATTGTAGTGGTGGTAGCTGCTACCTCCGGGACAACTGGTTCGACCCCTGGGGCCA GGGAGTGCATCC
GGGAACCCTGGTCACCGTCTCCTCA
6-1-8 TGTGCAAGA GGAATTTATGGTTCGGGGAGTCAGATCCCATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-1-9 TGTGCAAGA GGGGAGGTTGGAACGACACGAAAATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-1-10 TGTGCAAGA GGTCATAGCAGTGACTTATCCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA GGGAGTGCATCC
6-1-11 TGTGCAAGA GCTAGGGACCCGTGGACAAATGCTTCTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA GGGAGTGCATCC
6-1-12 TGTGCAAGA AGTATAGCAGCAGCTGGTACAGGTAGTGTTAGGTACTTCGATCTCTGGGGCCGTGGCACCCTGGTCACTGTCTCCTCA GGGAGTGCATCC
6-1-13 TGTGCAAAG TGGGCGGACTACTGGGGCCAGGGAAGCCCGGTCACCGTCTCCTCA GGGAGTGCATCC
6-1-15 TGTGCAAGA GCTAGGGACCCGTGGACAAATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA GGGAGTGCATCC
6-1-16 TGTGCAGGC AGTTTAACTGGGAATCTGGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-1-18 TGTGCAAGA GAGGGCCCCCTAAGGAACGGCTATTGTAGTGGTGGTAGCTGCTACCTCCGGGACAACTGGTTCGACCCCTGGGGCCA GGGAGTGCATCC
GGGAACCCTGGTCACCGTCTCCTCA
6-1-20 TGTGCAAGA GGGGAGGTTGGAACGACACGAAAATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-2-1 TGTGCAAGG CAACGTTATCGAGCTTTTGACATCTGGGGCCAAGGGACATCGGTTACTGTCTCCTCA GGGAGTGCATCC
6-2-3 TGTGCAAGA GATGACGACGGTTATGCTAATGCCTTTGACTCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-2-4 TGTACAAGA TCAGCGACTGGATCTTTACAGAACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-2-5 TGTGCAAGG TCGGAGCTCGTCGGGGGCGAAAGCCGGAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-2-6 TGTGCAAGA CAGTATGGGCACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-2-8 TGTGCAAAA AGGGGATTAGGGGGTGATGCTTTTGATGTCTGGGGCCAAGGGACAATGGTCATCGTCTCCTCA GGGAGTGCATCC
6-2-12 TGTGCAAGG GATGGGCCAGCAGCAACTGGTCTCCTTGACTACTGGGGTCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-2-13 TGTGCAAGA GAATTTTACCCGGGTATACCAGTGGCTGGTACCTCGGTATACTTCCAGCACTGGGGCCAGGGCACCCTGGTCACCGTC GGGAGTGCATCC
TCCTCA
6-2-14 TGTGCAAGA GATACCGGGTATAGCAGCAGCTGGTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-2-15 TGTGCAAGA GATCTTAGTGGGAGGTATCCGGACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-2-16 TGTGCAAGA GGTCTCGAGTATAGCAGCTCGAACTGGTTCGACCCCTGGGGCCAGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-2-18 TGTGCAAGA GGCCCAGGTGGGAGCTACCTATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCT GGGAGTGCATCC
6-2-19 TGTGCAAGA GATGGTGAACTGGGGATTGGTGACTACTGGGGCCAGGGAACCCTGGTCAGCGTCTCCTCA GGGAGTGCATCC
6-2-20 TGTACAAGA GACCGTACCCACTGCTTTGACTGCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-3-1 TGTGCAAGA GATCGAGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA GGGAGTGCATCC
6-3-2 TGTGCAAGA GGTTTGACTGGTTATTATATATTTCCCCCTTGGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-3-3 TGTGCAAGA GACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA GGGAGTGCATCC
6-3-4 TGTGCAAGG GGCCCCACGGGATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTTCGTCC
6-3-5 TGTGCAAGA GAGGGTATCGGAGCAGCAGCTGGTAAACCCGCATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-3-6 TGTGCAAGA GACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA GGGAGTGCATCC
6-3-7 TGTGCAAGA GGCCGTGCAGCAGCTGGTACAATTAGGAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-3-8 TGTGCAAGC GAGGTTTATAGCAGCAGCTGGGAGGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCCGTCTCTTCA GGGAGTGCATCC
6-3-9 TGTGCAAGA GATCCTGGGAATAGTGGGAGCTACTACGTTTGACGTTGGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-3-10 TGTGCAAGA GATCTGGCTATAGCAGTGGCTGGGCCGATCTGGTACTTCGATCTCTGGGGCCGTGGCACCCTGGTCACTGTCTCCTCA GGGAGTGCATCC
6-3-11 TGTGCAAGA GACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA GGGAGTGCATCC
6-3-12 TGTGCAAGA GAGGGGACTGGGGATAGGGGGGGGCTCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-3-14 TGTGCAAGA GGGATCTTAACTGCTGCCCCTTCATACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-3-15 TGTGCAAGA GCCTATTCTGGATACAATGATGCTTTTCATATCTGGGGCCAAGGGACACTGGTCACCGTCTCTTCA GGGAGTGCATCC
6-3-16 TGTGCAAGA GTTTCAAGTCAATATAGCAGCAGCTGGTACGAGGCGCCGGCGGGTGACTACTGGGGCCAGGGAACCCTGGTCACCGT GGGAGTGCATCC
CTCCTCA
6-3-17 TGTGCAAGA GTGCCACACCTGTATAGCAGCAGCTGGTAACACGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-3-19 TGTGCAAGA TCACCCAATTTAAGGGATTGGAACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA GGGAGTGCATCC
6-3-20 TGTGCAAGA GATCGCGACCCAGCAGCTCGGCACAAGCTTGGCACCGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGT GGGAGTGCATCC
CTCTTCA
Fig. 6. The nucleotide sequences of CDR3 / FR4 and adjacent regions of VH germ line gene segments of 54 clones homologous to X92224/J isolated from 3 different
patients are shown. 
there is little production of memory B-cells. Therefore,
before the IgA reaction in the coronary arteries takes place
as reported by Rowley et al.,15 a primary immune reaction,
in which IgM-secreting B cells are produced with a sub-
sequent class switch to IgA, probably has already taken
place in the peripheral blood. If this is true, then the B-cell
reaction observed in the peripheral blood in the acute phase
of KD could be an IgM reaction. Therefore, IgM secreting
B-cells rather than IgA secreting B-cells should be studied.
According to Leung et al.,18 a mechanism involved in
vasculitis of  KD is the presence of cytotoxic anti-endo-
thelial cell antibodies in the serum of patients that are
mostly comprised of IgM antibodies. Therefore, in the
study of pathogenesis of KD, the clonality of the IgM
transcripts which are expressed by the B-cells in the peri-
pheral blood in the acute phase of KD patients is of primary
importance. 
Similar to the superantigen of T-cells, the superantigen
of B-cells binds to the Fab portion of the VH3 immuno-
globulin. Staphylococcal protein A (SPA) is a representative
B-cell superantigen and binds mostly with IgM, specifically
with the FR3 portion, while some bind with the FR1 and
the 3’ end of the CDR2.21 Among the B cell repertoire in
the peripheral blood, the VH3 family is most commonly
Hyun Hee Lee, et al.
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Clone No FR1 CDR1 FR2 CDR2 FR3 FR CDR Homology
S R S R S R S R S R S R S R (%)
6-1-1 3 2 0 2 1 0 0 1 4 5 8 7 0 3   94.2
6-1-2 0 0  0 0 0 0  0 1 3 3 3 3 0 1   97.8 
6-1-3 0 0  0 0 0 0  0 0 1 2 1 2 0 0   99.0
6-1-5 0 0  0 0 0 1  0 1 3 1 3 2 0 1   98.1
6-1-6 0 0  0 0 0 0  0 0 0 0 0 0 0 0  100.0
6-1-7 0 0  0 0 0 0  0 0 0 0 0 0 0 0  100.0
6-1-8 1 0  1 0 1 0  0 0 0 0 2 0 1 0   99.0
6-1-9 0 0  0 0 0 0  0 0 1 1 1 1 0 0   99.4
6-1-10 0 0  0 0 0 0  0 0 1 3 1 3 0 0   98.7
6-1-11 0 0  0 0 1 0  0 0 0 0 1 0 0 0   99.7
6-1-12 0 0  0 0 0 0  0 1 2 2 2 2 0 1   98.4
6-1-13 1 1  0 1 0 0  0 0 6 3 7 4 0 2   96.2
6-1-15 0 1  0 0 0 0  0 0 0 0 0 1 0 0   99.7
6-1-16 1 1  0 0 0 1  0 1 4 4 5 6 0 1   96.2
6-1-18 0 0  0 0 0 0  0 0 0 0 0 0 0 0  100.0
6-1-20 0 0  0 0 0 0  0 0 0      38     0     38       0 0   71.5
6-2-1 3 2  2 3 1 1  0 5 6 6    10      9 2 8   90.7
6-2-3 0 0  0 1 0 0  1 2 2 4 2 4 1 3   96.8
6-2-4 1 0 0 2 1 1  0 1 4 2 6 3 0 3   96.2
6-2-5 1 0  0 0 0 0  0 0 0 0 1 0 0 0   99.7
6-2-6 1 1  1 2 0 0  0 0 1 2 2 3 1 2   97.4
6-2-8 0 0  1 1 0 0  2 2 5 4 5 4 3 3   95.2
6-2-12 1 0  0 3 0 0  1 1 3 4 7 4 1 1   95.8
6-2-13 0 0  0 0 0 0  0 0 0 0 0 0 0 0  100.0
6-2-14 0 0  0 0 0 0  0 0 0     14 0 14 0 0   88.8
6-2-15 1 0  0 0 0 0  1 0 1 3 2 3 1 0   98.1
6-2-16 0 0  0 0 0 0  0 0 1 0  1 0 0 0   99.7
6-2-18 1 1  3 2 0 0  0 1 1 2 2 3 3 3   96.5
6-2-19 0 0  0 0 0 1  0 1 1 0 1 1 0 1   99.0
6-2-20 1 0  0 0 0 0  0 1 0 1 1 1 0 1   99.0
6-3-1 1 0  0 0 0 0  0 0 0 1 1 1 0 0   99.4
6-3-2 1 0  0 0 0 0  0 0 0 1 1 1 0 0    99.4
6-3-3 0 0  0 0 0 0  0 0 0 1 0 1 0 0   99.7
6-3-4 0 0  0 0 0 0  0 0 0 0 0 0 0 0  100.0
6-3-5 0 0  0 0 0 0  2 2 0 34 0 34          2  2   71.2
6-3-6 0 0  0 0 0 0  0 0 0 1 0 1 0 0   99.7
6-3-7 0 0  0 0 0 1  0 0 1 0 1 1 0 0   99.4
6-3-8 0 0  1 0 0 0  0 0 0 1 0 1 1 0   99.4
6-3-9 0 0  0 0 0 0  0 0 0 0 0 0 0 0  100.0
6-3-10 0 0  0 0 0 1  0 0 2 0 2 1 0 0   99.0
6-3-11 0 0  0 0 0 0  0 0 1 0 1 0 0 0   99.7
6-3-12 0 0  0 0 0 0  0 0 0 0 0 0 0 0  100.0
6-3-14 0 0 0 0 0 0  0 0 0 0 0 0 0 0  100.0
6-3-15 0 1  0 0 0 1  0 1 2 0 2 2 0 1   98.4
6-3-16 0 0  0 0 0 1  0 0 0 0 0 1 0 0   99.7
6-3-17 0 0  0 0 0 0  0 0 0 0 0 0 0 0  100.0
6-3-19 0 0  0 0 0 0  0 0 0 0 0 0 0 0  100.0
6-3-20 0 1  0 0 0 0  0 0 0 1 0 2 0 0   99.4
Fig. 7. Mutation analysis of 48 X92224/J derived clones from peripheral B cells of 3 different patients.
used, therefore, the VH3 family clones are probably the most
numerous. Thus, if there is a superantigen stimulus, the
clone that belongs to a specific VH family should increase
or significantly decrease. For example, according to the
theory of Hillson et al.,21 the VH3 family should comprise
most of the cloned IgM transcripts. However, a similar
number of VH1 family and VH6 family clones were obtained
and significantly decreased number of VH family clones
could not be observed. 
Furthermore, the germ line genes used among the 314
clones were 17.3% for M99686 derived clones and 15.4%
for X92224/J derived clones, showing that there were
numerous clones using similar germ line genes. There
were slight differences in the most commonly used germ
line genes, nevertheless, most patients used similar germ
line genes, thus supporting the oligoclonality of B-cells.
Also, these 2 clones do not come from the superantigen-
stimulated VH3 family, but rather M99686 is a clone of the
VH5 family and X92224/J is a clone of the VH6 family.
Although the presence of clonally related sequences might
be due to simply isolation of the sequence from the same
plasma cell by chance, it is very unlikely. An interesting
observation was that the sequence of two clones (5-1-8
clone and the 5-3-4 clone) from different patients, showed
99.5% homology, which suggests that the sequence could
not have been isolated from the same plasma cell. There-
fore, these findings suggest that these KD patients might
be from same antigenic stimulus.
Since the B-cell superantigen binds with the FR portion
rather than the CDR portion of the immunoglobulin mole-
cule, it is known that few somatic hypermutations occur.22
Generally, the R/S ratio is 2.9 when random mutations
occur.23 The R/S ratio is less than 2.9 when selection occurs
to maintain the amino acid base sequence and the ratio is
more than 2.9 when selection leans towards diversity.24
When there is no change to maintain function, such as the
FR of the antibody, the R/S ratio should be less than 1.5.
On the other hand, if the R/S ratio of the CDR of the anti-
body produced in response to an antigen is more than 2.9,
this indicates that the clone containing the antigen-binding
site with high affinity for the antigen is positively selected.25
In the present study, it was difficult to analyze all the sequ-
ences of the clones. Nevertheless, the fact that the R/S ratio
of the CDR clones with similar base sequences was more
than 2.9 indicated that positive selection took place, provid-
ing evidence for selection because of a conventional antigen
stimulus. Furthermore, the R/S ratio of the most commonly
used germ line genes M99686 and X92224/J was more
than 2.9 and the diverse sizes of CDR3 showed that the
clonal expansion was due to a conventional antigen stimulus
rather than a superantigen stimulus.
In conclusion, we showed that the diverse immuno-
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<—
5-3-8 1 ATGGGGTCAACCGCCATCCTCGCCCTCCTCCTGGCTGTTCTCCAAGGAGTCTGCGCCGAG 60 
5-7-4 1 .....................................................................................................................................................T............................... 60 
——————————————— FR1 ——————————————-——
5-3-8 61 GTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCC 120 
5-7-4 61 ...........................................................................................................G............................................................................. 120 
——————-> <————— CDR1 —————> <——————— FR2 —-—— 
5-3-8 121 TGTAAGGGTTCTGGATACAGCTTTACCAGCTACTGGATCGGCTGGGTGCGCCAGATGCCC 180 
5-7-4 121 ........................................................................................................................................................................................ 180 
—————————————-> <—————- CDR2 ——————> <————
5-3-8 181 GGGAAAGGCCTGGAGTGGATGGGGATCATCTATCCTGGTGACTCTGATACCAGATATAGC 240 
5-7-4 181 .......................................................................................................................................................................................... 240 
—————————————— FR3 ————————————————— 
5-3-8 241 CCGTCCTTCCAAGGCCAGGTCACAATCTCAGCCGACAAGTCCATCAGCACCGCCTACCTG 300 
5-7-4 241 ....................................................................................................................................................................................... 300 
———————————————————————> <————————— 
5-3-8 301 TAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCACGTACTACTGTGCGAGACGGCCTTAT 360 
5-7-4 301 ...........................................................................................................T............................................................................ 360 
——————————————— CDR3 ——————————————— 
5-3-8 361 TACGATATCTTGACTGGCTCTGATGCTTTTGACATCTGGGGCCAAGGGACAATGGTCACC 420 
5-7-4 361 ...................................................................................................................................................................................... 420 
————> <————-—-—- C µ ———————————————-—
5-3-8 421 GTCTCTTCAGGGAGTGCATCCGCCCCAACCCTTTTCCCCCTCGTCTTCTAGAGC 474 
5-7-4 421 .................................................................................................................................................................. 474
Fig. 8. Sequence alignment of 5-1-8 (patient #1) vs. 5-3-4 (patient #3) clones. The sequence of clones showed almost identical alignment. 
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globulin somatic mutations that occur in response to an
antigen stimulus are due to antibody affinity maturation,
and that the B-cell IgM transcripts in the peripheral blood
of KD are due to a conventional antigen stimulus rather
than a superantigen stimulus, as Rowley et al.16 reported
recently. Furthermore, the IgM produced from peripheral
B cells in acute KD is oligoclonal, consistent with a con-
ventional antigen-driven immune response.
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